Cargando…

Effect of TIM-3 Blockade on the Immunophenotype and Cytokine Profile of Murine Uterine NK Cells

NK cells are the most abundant lymphocyte population in the feto-maternal interface during gestation. The uterine NK cells (uNK) are transient, have a unique immunophenotype and produce a number of cytokines. These cytokines play an important role in establishment and maintenance of vascular remodel...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tripathi, Sudipta, Chabtini, Lola, Dakle, Pranal J., Smith, Brian, Akiba, Hisaya, Yagita, Hideo, Guleria, Indira
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4405344/ https://www.ncbi.nlm.nih.gov/pubmed/25897749 http://dx.doi.org/10.1371/journal.pone.0123439

Ejemplares similares

The effectiveness of a novel treatment of TIM‐3(−) NK cells infusion in murine models of immune‐mediated bone marrow failure
por: Ding, Shaoxue, et al.
Publicado: (2023)

Tim-4 Inhibits NO Generation by Murine Macrophages
por: Xu, Li-yun, et al.
Publicado: (2015)

Differential engagement of Tim-1 during activation can positively or negatively costimulate T cell expansion and effector function
por: Xiao, Sheng, et al.
Publicado: (2007)

Blockade of the Programmed Death-1 (PD1) Pathway Undermines Potent Genetic Protection from Type 1 Diabetes
por: Kochupurakkal, Nora M., et al.
Publicado: (2014)

Combined TIM-3 blockade and CD137 activation affords the long-term protection in a murine model of ovarian cancer
por: Guo, Zhiqiang, et al.
Publicado: (2013)

A case of lymphoproliferative disorder of NK-cells: aggressive immunophenotype but indolent behavior
por: Shi, Min, et al.
Publicado: (2015)

Galectin-9-Mediated Protection from Allo-Specific T Cells as a Mechanism of Immune Privilege of Corneal Allografts
por: Shimmura-Tomita, Machiko, et al.
Publicado: (2013)

Murine Tim-1 is excluded from the immunological synapse
por: Lin, Jean, et al.
Publicado: (2012)

TIM-3 and TIM-1 Could Regulate Decidual γδTCR Bright T Cells during Murine Pregnancy
por: Nörenberg, Jasper, et al.
Publicado: (2019)

Murine brain tumor microenvironment immunophenotyping using mass cytometry
por: McClellan, Brandon L., et al.
Publicado: (2022)

Tim-3 Expression Causes NK Cell Dysfunction in Type 2 Diabetes Patients
por: Wang, Hui, et al.
Publicado: (2022)

Blockade of Death Ligand TRAIL Inhibits Renal Ischemia Reperfusion Injury
por: Adachi, Takaomi, et al.
Publicado: (2013)

Tim-3 Is Upregulated in NK Cells during Early Pregnancy and Inhibits NK Cytotoxicity toward Trophoblast in Galectin-9 Dependent Pathway
por: Sun, Jintang, et al.
Publicado: (2016)

Tim‐3 blockade promotes iNKT cell function to inhibit HBV replication
por: Xu, Yong, et al.
Publicado: (2018)

Targeting Tim-3 in Cancer With Resistance to PD-1/PD-L1 Blockade
por: Tian, Tian, et al.
Publicado: (2021)

Indirect Impact of PD-1/PD-L1 Blockade on a Murine Model of NK Cell Exhaustion
por: Alvarez, Maite, et al.
Publicado: (2020)

Blockade of checkpoint receptor PVRIG unleashes anti-tumor immunity of NK cells in murine and human solid tumors
por: Li, Yangyang, et al.
Publicado: (2021)

TIM-3 Expression Is Downregulated on Human NK Cells in Response to Cancer Targets in Synergy with Activation
por: Dao, Tram N., et al.
Publicado: (2020)

Immunophenotype
por: Albani, Salvatore
Publicado: (2014)

Peripheral Blood TIM-3 Positive NK and CD8+ T Cells throughout Pregnancy: TIM-3/Galectin-9 Interaction and Its Possible Role during Pregnancy
por: Meggyes, Matyas, et al.
Publicado: (2014)

TIGIT(+) TIM-3(+) NK cells are correlated with NK cell exhaustion and disease progression in patients with hepatitis B virus‑related hepatocellular carcinoma
por: Yu, Lihua, et al.
Publicado: (2021)

Comprehensive Analysis and Summary of the Value of Immunophenotypes of Mature NK Cell Tumors for Differential Diagnosis, Treatment, and Prognosis
por: Pu, Qiyao, et al.
Publicado: (2022)

Blockade of TIM3 relieves immunosuppression through reducing regulatory T cells in head and neck cancer
por: Liu, Jian-Feng, et al.
Publicado: (2018)

IMMU-08. MICROENVIRONMENT MODULATION BY TIM-3 BLOCKADE IMPROVES THE OUTCOME OF PRECLINICAL DIPG MODELS
por: Ausejo-Mauleon, Iker, et al.
Publicado: (2021)

Tim-3 Blockade Elicits Potent Anti-Multiple Myeloma Immunity of Natural Killer Cells
por: Jiang, Wen, et al.
Publicado: (2022)

OX40 (CD134) Controls Memory T Helper 2 Cells that Drive Lung Inflammation
por: Salek-Ardakani, Shahram, et al.
Publicado: (2003)

The Role of Tim-3 on dNK Cells Dysfunction During Abnormal Pregnancy With Toxoplasma gondii Infection
por: Li, Teng, et al.
Publicado: (2021)

TIM-3 levels correlate with enhanced NK cell cytotoxicity and improved clinical outcome in AML patients
por: Rakova, Jana, et al.
Publicado: (2021)

The Emerging Role of NK Cells in Immune Checkpoint Blockade
por: Martinez-Perez, Alejandra, et al.
Publicado: (2022)

Blockade of CTLA-4 and Tim-3 pathways induces fetal loss with altered cytokine profiles by decidual CD4(+)T cells
por: Wang, Songcun, et al.
Publicado: (2019)

Identification of an Autophagy-Related Risk Signature Correlates With Immunophenotype and Predicts Immune Checkpoint Blockade Efficacy of Neuroblastoma
por: Kang, Wenjuan, et al.
Publicado: (2021)

Stratification of PD-1 blockade response in melanoma using pre- and post-treatment immunophenotyping of peripheral blood
por: Edner, Natalie M, et al.
Publicado: (2023)

Sequential activation of NKT cells and NK cells provides effective innate immunotherapy of cancer
por: Smyth, Mark J., et al.
Publicado: (2005)

Mast cell activation is enhanced by Tim1:Tim4 interaction but not by Tim-1 antibodies
por: Phong, Binh, et al.
Publicado: (2016)

Natural Killer T-Cell Agonist α-Galactosylceramide and PD-1 Blockade Synergize to Reduce Tumor Development in a Preclinical Model of Colon Cancer
por: Wang, Ying, et al.
Publicado: (2020)

Dual but not single PD-1 or TIM-3 blockade enhances oncolytic virotherapy in refractory lung cancer
por: Sun, Fan, et al.
Publicado: (2020)

Increased TIM-3(+)PD-1(+) NK cells are associated with the disease activity and severity of systemic lupus erythematosus
por: Luo, Qing, et al.
Publicado: (2021)

Genetically engineered murine pancreatic cancer models approximate immunophenotypic properties of human patients
por: Mace, Thomas A, et al.
Publicado: (2013)

The effect of pregnancy on the uterine NK cell KIR repertoire
por: Male, Victoria, et al.
Publicado: (2011)

Tim Burton /
por: Marcos Arza, Marcos
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_p654cmpdfff7ccbm4hoeg5tqfn